AI assistant
Sending…
Axogen, Inc. — Director's Dealing 2017
Mar 15, 2017
32414_dirs_2017-03-14_9fabe12f-5451-48c4-9b01-e52481cbf173.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-03-14
Reporting Person: Donovan Michael Patrick (VP Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-14 | Common Stock | M | 4659 | $0.27 | Acquired | 4659 | Direct |
| 2017-03-14 | Common Stock | M | 5000 | $2.74 | Acquired | 9659 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-14 | Employee Stock Option (right to purchase) | $0.27 | M | 4659 | Acquired | 2018-01-13 | Common Stock (4659) | Direct |
| 2017-03-14 | Employee Stock Option (right to purchase) | $2.74 | M | 5000 | Acquired | 2018-12-16 | Common Stock (35000) | Direct |
More from Axogen, Inc.
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3